EXPLORE THE SCIENCE
TL;DR: Seizures can sometimes steal a person’s ability to speak or understand language for hours or days without causing convulsions, and they can look just like a stroke. A review of 87 reported patients found that 1 in 5 attacks left lasting language problem…
Read article
TL;DR: A 2026 systematic review and meta-analysis in Pain Medicine found that Medicaid enrollment and preoperative benzodiazepine use had the largest pooled associations with new persistent opioid use after surgery among opioid-naive US adults. Key Findings 27…
Read article
TL;DR: A 2026 review in CNS Drugs argues that seletracetam, an unapproved SV2A-targeting antiseizure drug, may deserve renewed development as a low-volume intranasal non-benzodiazepine rescue treatment for acute repetitive seizures. Key Findings SV2A racetam:…
Read article
TL;DR: A 2026 nationwide study in PLOS One found that adults age 40 and older in Iceland often had psychiatric diagnoses and psychotropic medication fills, with 20.8% receiving a diagnosis in the prior year and 34.2% filling at least one psychotropic prescript…
Read article
TL;DR: A 2026 study in Drug Design, Development and Therapy validated liquid chromatography-tandem mass spectrometry (LC-MS/MS), a high-specificity lab method, to screen serum for 77 neuropsychiatric drugs and then applied it to 1,021 clinical specimens over 3…
Read article
TL;DR: A 2026 systematic review in European Archives of Psychiatry and Clinical Neuroscience argues that catatonia, a syndrome of freezing, mutism, and abnormal movement, may involve underweighted limbic-system circuitry linking emotional regulation with motor…
Read article
Recreational drug use is constantly evolving, with new substances emerging and old drugs being used in new ways. This can pose risks, especially for the developing adolescent brain. Key Facts: Use of designer opioids like fentanyl is skyrocketing, causing a ri…
Read article